qPCR Reagents Market by Detection (Dye-based, Probe-based), Packaging (qPCR Core Kits, Master Mixes), End User (Hospitals, Diagnostic Centers, Academia, Research Labs, CRO), Application (Diagnostic, Research, Forensic) - Global Forecasts to 2020
The Global qPCR reagents market is poised to reach ~USD 1,893.9 million by 2020 From USD 1,307.0 million in 2015, growing at a CAGR of 7.7%, during 2015 to 2020. North America is expected to hold the largest share of the global qPCR reagents market in 2015. Market growth of qPCR reagents is being propelled by rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market.
In this report, the global qPCR reagents market is segmented on the basis detection method (dye-based and probe & primer-based qPCR reagents), packaging type (core kits and mastermixes), end user (hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, clinical research organizations, and forensic laboratories), and application (diagnostic, research, and forensic).
The qPCR core kits segment is expected to account for the larger share of the global qPCR reagents market in 2015, followed by mastermixes. Significant demand growth for qPCR core kits is owing to low prices of core kits (as compared to mastermixes), flexibility offered to end users (as it is best suited for researchers to develop independent reaction protocols), growing private-public funding for life science research, and increasing market availability of qPCR core kits across major countries.
Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the global qPCR reagents market in 2015, followed by Europe. Asia-Pacific is poised to grow at the highest CAGR during the forecast period, owing to factors such as growing incidences of criminal cases across the globe, improving knowledge about human and microbial genome, increasing laboratory automation in forensic laboratories, and various statistical and technical advancements in the field of qPCR.
The global qPCR reagents market is highly competitive, with various global as well as local players. In 2014, the global qPCR reagents devices market was dominated by Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), and Qiagen N.V. (Netherlands); which together accounted for ~75.0% of the qPCR reagents market. New product launches, agreements, collaborations, partnerships, geographic expansions, mergers, demergers, strategic acquisitions, awareness campaigns, and offering research fund & grants are the major strategies adopted by most market players to achieve growth in the global qPCR reagents market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis such as market share analysis of the top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the qPCR reagents market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms to garner higher market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
In this report, the global qPCR reagents market is segmented on the basis detection method (dye-based and probe & primer-based qPCR reagents), packaging type (core kits and mastermixes), end user (hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, clinical research organizations, and forensic laboratories), and application (diagnostic, research, and forensic).
The qPCR core kits segment is expected to account for the larger share of the global qPCR reagents market in 2015, followed by mastermixes. Significant demand growth for qPCR core kits is owing to low prices of core kits (as compared to mastermixes), flexibility offered to end users (as it is best suited for researchers to develop independent reaction protocols), growing private-public funding for life science research, and increasing market availability of qPCR core kits across major countries.
Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the global qPCR reagents market in 2015, followed by Europe. Asia-Pacific is poised to grow at the highest CAGR during the forecast period, owing to factors such as growing incidences of criminal cases across the globe, improving knowledge about human and microbial genome, increasing laboratory automation in forensic laboratories, and various statistical and technical advancements in the field of qPCR.
The global qPCR reagents market is highly competitive, with various global as well as local players. In 2014, the global qPCR reagents devices market was dominated by Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), and Qiagen N.V. (Netherlands); which together accounted for ~75.0% of the qPCR reagents market. New product launches, agreements, collaborations, partnerships, geographic expansions, mergers, demergers, strategic acquisitions, awareness campaigns, and offering research fund & grants are the major strategies adopted by most market players to achieve growth in the global qPCR reagents market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis such as market share analysis of the top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the qPCR reagents market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms to garner higher market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the qPCR reagents offered by the top 10 players in the global market. The report analyzes the qPCR reagents market by detection method, packaging type, end user, and application across key geographic regions
- Product Development/Innovation: Detailed insights on upcoming qPCR reagents, research and development activities, and new product launches in the market
- Market Development: Comprehensive information on lucrative emerging markets. The report analyzes the markets for various qPCR reagents across key geographic regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global qPCR reagents market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global qPCR reagents market
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.2 FACTOR ANALYSIS
2.2.1 INTRODUCTION
2.2.2 DEMAND-SIDE ANALYSIS
2.2.2.1 Healthcare expenditure patterns
2.2.2.2 Rapid growth of aging population
2.2.2.3 Incidence and prevalence of cancer
2.2.2.4 Birth rate/pregnancies
2.2.2.5 Burden of infectious diseases
2.2.2.6 Number of clinical, forensic, and research laboratories
2.2.3 SUPPLY-SIDE ANALYSIS
2.2.3.1 Number of new product launches: qPCR Reagents Vs. Competitive Technologies
2.2.3.2 Parent market analysis: Polymerase chain reaction (PCR) market
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.5.1 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 HISTORY, EVOLUTION, AND CURRENT SCENARIO
3.3 FUTURE OUTLOOK
3.4 CONCLUSION
4 PREMIUM INSIGHTS
4.1 GLOBAL qPCR REAGENTS MARKET (2015–2020)
4.2 GLOBAL qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD (2015 VS. 2020)
4.3 GLOBAL qPCR REAGENTS MARKET SHARE, BY PACKAGING TYPE (2015)
4.4 GLOBAL qPCR REAGENTS MARKET SIZE, BY APPLICATION (2015)
4.5 GLOBAL qPCR REAGENTS MARKET SIZE, BY END USER (2015 VS. 2020)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.3 MARKET DYNAMICS
5.3.1 KEY MARKET DRIVERS
5.3.1.1 Rising incidence of infectious diseases and genetic disorders
5.3.1.2 Growing geriatric population
5.3.1.3 Technological advancements
5.3.1.4 Increasing public-private investments, funds, and grants
5.3.1.5 Successful completion of the human genome project
5.3.2 KEY MARKET RESTRAINTS
5.3.2.1 Technical limitations associated with qPCR
5.3.3 KEY MARKET OPPORTUNITIES
5.3.3.1 Growing market penetration in emerging countries
5.3.3.2 Shift from plant-derived to genome-based drug discovery
5.3.4 KEY MARKET CHALLENGES
5.3.4.1 Adoption and implementation of MIQE guidelines for publishing qPCR-based research
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 SUPPLY CHAIN ANALYSIS
6.4 INDUSTRY TRENDS
6.5 PORTER’S FIVE FORCES ANALYSIS
6.5.1 THREAT FROM NEW ENTRANTS
6.5.2 THREAT FROM SUBSTITUTES
6.5.3 BARGAINING POWER OF SUPPLIERS
6.5.4 BARGAINING POWER OF BUYERS
6.5.5 INTENSITY OF COMPETITIVE RIVALRY
7 QPCR REAGENTS MARKET, BY DETECTION METHOD
7.1 INTRODUCTION
7.2 DYE-BASED qPCR REAGENTS
7.3 PROBES AND PRIMER-BASED qPCR REAGENTS
8 QPCR REAGENTS MARKET, BY PACKAGING TYPE
8.1 INTRODUCTION
8.2 qPCR CORE KITS
8.3 qPCR MASTERMIXES
9 QPCR REAGENTS MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS & DIAGNOSTIC CENTERS
9.3 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.5 CLINICAL RESEARCH ORGANIZATIONS (CROS)
9.6 FORENSIC LABORATORIES
10 QPCR REAGENTS MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 DIAGNOSTIC APPLICATIONS
10.3 RESEARCH APPLICATIONS
10.4 FORENSIC APPLICATIONS
11 QPCR REAGENTS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 U.S.
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 U.K.
11.3.3 FRANCE
11.3.4 REST OF EUROPE (RoE)
11.4 ASIA-PACIFIC
11.4.1 JAPAN
11.4.2 CHINA
11.4.3 INDIA
11.4.4 REST OF ASIA-PACIFIC (RoAPAC)
11.5 REST OF THE WORLD (ROW)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET SHARE ANALYSIS
12.3 COMPETITIVE SCENARIO
12.4 RECENT DEVELOPMENTS
12.4.1 NEW PRODUCT LAUNCHES AND PRODUCT APPROVALS
12.4.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
12.4.3 MERGERS, DEMERGERS, AND ACQUISITIONS
12.4.4 EXPANSION
13 COMPANY PROFILE
13.1 INTRODUCTION
13.1.1 GEOGRAPHIC BENCHMARKING
13.1.2 STRATEGIC BENCHMARKING
13.1.2.1 Product development and commercialization
13.2 THERMO FISHER SCIENTIFIC INC.
13.3 BIO-RAD LABORATORIES, INC.
13.4 F. HOFFMAN-LA ROCHE LTD.
13.5 QIAGEN N.V.
13.6 AGILENT TECHNOLOGIES, INC.
13.7 TAKARA BIO INC.
13.8 AFFYMETRIX, INC.
13.9 SIGMA-ALDRICH CORPORATION (A SUBSIDIARY OF MERCK KGAA, GERMANY)
13.10 PROMEGA CORPORATION
13.11 QUANTA BIOSCIENCES, INC.
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORTS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.2 FACTOR ANALYSIS
2.2.1 INTRODUCTION
2.2.2 DEMAND-SIDE ANALYSIS
2.2.2.1 Healthcare expenditure patterns
2.2.2.2 Rapid growth of aging population
2.2.2.3 Incidence and prevalence of cancer
2.2.2.4 Birth rate/pregnancies
2.2.2.5 Burden of infectious diseases
2.2.2.6 Number of clinical, forensic, and research laboratories
2.2.3 SUPPLY-SIDE ANALYSIS
2.2.3.1 Number of new product launches: qPCR Reagents Vs. Competitive Technologies
2.2.3.2 Parent market analysis: Polymerase chain reaction (PCR) market
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.5.1 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 HISTORY, EVOLUTION, AND CURRENT SCENARIO
3.3 FUTURE OUTLOOK
3.4 CONCLUSION
4 PREMIUM INSIGHTS
4.1 GLOBAL qPCR REAGENTS MARKET (2015–2020)
4.2 GLOBAL qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD (2015 VS. 2020)
4.3 GLOBAL qPCR REAGENTS MARKET SHARE, BY PACKAGING TYPE (2015)
4.4 GLOBAL qPCR REAGENTS MARKET SIZE, BY APPLICATION (2015)
4.5 GLOBAL qPCR REAGENTS MARKET SIZE, BY END USER (2015 VS. 2020)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.3 MARKET DYNAMICS
5.3.1 KEY MARKET DRIVERS
5.3.1.1 Rising incidence of infectious diseases and genetic disorders
5.3.1.2 Growing geriatric population
5.3.1.3 Technological advancements
5.3.1.4 Increasing public-private investments, funds, and grants
5.3.1.5 Successful completion of the human genome project
5.3.2 KEY MARKET RESTRAINTS
5.3.2.1 Technical limitations associated with qPCR
5.3.3 KEY MARKET OPPORTUNITIES
5.3.3.1 Growing market penetration in emerging countries
5.3.3.2 Shift from plant-derived to genome-based drug discovery
5.3.4 KEY MARKET CHALLENGES
5.3.4.1 Adoption and implementation of MIQE guidelines for publishing qPCR-based research
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 SUPPLY CHAIN ANALYSIS
6.4 INDUSTRY TRENDS
6.5 PORTER’S FIVE FORCES ANALYSIS
6.5.1 THREAT FROM NEW ENTRANTS
6.5.2 THREAT FROM SUBSTITUTES
6.5.3 BARGAINING POWER OF SUPPLIERS
6.5.4 BARGAINING POWER OF BUYERS
6.5.5 INTENSITY OF COMPETITIVE RIVALRY
7 QPCR REAGENTS MARKET, BY DETECTION METHOD
7.1 INTRODUCTION
7.2 DYE-BASED qPCR REAGENTS
7.3 PROBES AND PRIMER-BASED qPCR REAGENTS
8 QPCR REAGENTS MARKET, BY PACKAGING TYPE
8.1 INTRODUCTION
8.2 qPCR CORE KITS
8.3 qPCR MASTERMIXES
9 QPCR REAGENTS MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS & DIAGNOSTIC CENTERS
9.3 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.5 CLINICAL RESEARCH ORGANIZATIONS (CROS)
9.6 FORENSIC LABORATORIES
10 QPCR REAGENTS MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 DIAGNOSTIC APPLICATIONS
10.3 RESEARCH APPLICATIONS
10.4 FORENSIC APPLICATIONS
11 QPCR REAGENTS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 U.S.
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 U.K.
11.3.3 FRANCE
11.3.4 REST OF EUROPE (RoE)
11.4 ASIA-PACIFIC
11.4.1 JAPAN
11.4.2 CHINA
11.4.3 INDIA
11.4.4 REST OF ASIA-PACIFIC (RoAPAC)
11.5 REST OF THE WORLD (ROW)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET SHARE ANALYSIS
12.3 COMPETITIVE SCENARIO
12.4 RECENT DEVELOPMENTS
12.4.1 NEW PRODUCT LAUNCHES AND PRODUCT APPROVALS
12.4.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
12.4.3 MERGERS, DEMERGERS, AND ACQUISITIONS
12.4.4 EXPANSION
13 COMPANY PROFILE
13.1 INTRODUCTION
13.1.1 GEOGRAPHIC BENCHMARKING
13.1.2 STRATEGIC BENCHMARKING
13.1.2.1 Product development and commercialization
13.2 THERMO FISHER SCIENTIFIC INC.
13.3 BIO-RAD LABORATORIES, INC.
13.4 F. HOFFMAN-LA ROCHE LTD.
13.5 QIAGEN N.V.
13.6 AGILENT TECHNOLOGIES, INC.
13.7 TAKARA BIO INC.
13.8 AFFYMETRIX, INC.
13.9 SIGMA-ALDRICH CORPORATION (A SUBSIDIARY OF MERCK KGAA, GERMANY)
13.10 PROMEGA CORPORATION
13.11 QUANTA BIOSCIENCES, INC.
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORTS
LIST OF TABLES
TABLE 1 qPCR REAGENTS INDUSTRY FOCUSES ON TECHNOLOGICAL INTEGRATION TO DEVELOP ADVANCED PRODUCTS WITH DIVERSE APPLICATION AREAS
TABLE 2 qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013–2020 (USD MILLION)
TABLE 3 DYE-BASED qPCR REAGENTS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
TABLE 4 PROBES & PRIMER-BASED qPCR REAGENTS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
TABLE 5 qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013–2020 (USD MILLION)
TABLE 6 qPCR REAGENTS MARKET SIZE FOR CORE KITS, BY REGION, 2013–2020 (USD MILLION)
TABLE 7 qPCR REAGENTS MARKET SIZE FOR MASTERMIXES, BY REGION, 2013–2020 (USD MILLION)
TABLE 8 GLOBAL qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 9 qPCR REAGENTS MARKET SIZE FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2013-2020 (USD MILLION)
TABLE 10 qPCR REAGENTS MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2013-2020 (USD MILLION)
TABLE 11 qPCR REAGENTS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION)
TABLE 12 qPCR REAGENTS MARKET SIZE FOR CROS, BY REGION, 2013-2020 (USD MILLION)
TABLE 13 qPCR REAGENTS MARKET SIZE FOR FORENSIC LABORATORIES, BY REGION, 2013-2020 (USD MILLION)
TABLE 14 GLOBAL qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 15 qPCR REAGENTS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
TABLE 16 qPCR REAGENTS MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
TABLE 17 qPCR REAGENTS MARKET SIZE FOR FORENSIC APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
TABLE 18 qPCR REAGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
TABLE 19 NORTH AMERICA: qPCR REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
TABLE 20 U.S.: QPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 21 U.S.: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 22 U.S.: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 23 U.S.: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 24 CANADA: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 25 CANADA: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 26 CANADA: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 27 CANADA: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 28 EUROPE: qPCR REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
TABLE 29 GERMANY: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 30 GERMANY: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 31 GERMANY: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 32 GERMANY: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 33 U.K.: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 34 U.K.: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 35 U.K.: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 36 U.K.: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 37 FRANCE: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 38 FRANCE: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 39 FRANCE: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 40 FRANCE: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 41 ROE: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 42 ROE: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 43 ROE: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 44 ROE: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 45 ASIA-PACIFIC qPCR REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
TABLE 46 JAPAN: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 47 JAPAN: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 48 JAPAN: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 49 JAPAN: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 50 CHINA: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 51 CHINA: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 52 CHINA: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 53 CHINA: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 54 INDIA: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 55 INDIA: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 56 INDIA: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 57 INDIA: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 58 ROAPAC: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 59 ROAPAC: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 60 ROAPAC: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 61 ROAPAC: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 62 ROW: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 63 ROW: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 64 ROW: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 65 ROW: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 66 NEW PRODUCT LAUNCHES AND PRODUCT APPROVALS, 2012–2015
TABLE 67 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012–2015
TABLE 68 MERGERS, DEMERGERS, AND ACQUISITIONS, 2012–2015
TABLE 69 GEOGRAPHICAL EXPANSIONS, 2012–2015
TABLE 1 qPCR REAGENTS INDUSTRY FOCUSES ON TECHNOLOGICAL INTEGRATION TO DEVELOP ADVANCED PRODUCTS WITH DIVERSE APPLICATION AREAS
TABLE 2 qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013–2020 (USD MILLION)
TABLE 3 DYE-BASED qPCR REAGENTS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
TABLE 4 PROBES & PRIMER-BASED qPCR REAGENTS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
TABLE 5 qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013–2020 (USD MILLION)
TABLE 6 qPCR REAGENTS MARKET SIZE FOR CORE KITS, BY REGION, 2013–2020 (USD MILLION)
TABLE 7 qPCR REAGENTS MARKET SIZE FOR MASTERMIXES, BY REGION, 2013–2020 (USD MILLION)
TABLE 8 GLOBAL qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 9 qPCR REAGENTS MARKET SIZE FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2013-2020 (USD MILLION)
TABLE 10 qPCR REAGENTS MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2013-2020 (USD MILLION)
TABLE 11 qPCR REAGENTS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION)
TABLE 12 qPCR REAGENTS MARKET SIZE FOR CROS, BY REGION, 2013-2020 (USD MILLION)
TABLE 13 qPCR REAGENTS MARKET SIZE FOR FORENSIC LABORATORIES, BY REGION, 2013-2020 (USD MILLION)
TABLE 14 GLOBAL qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 15 qPCR REAGENTS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
TABLE 16 qPCR REAGENTS MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
TABLE 17 qPCR REAGENTS MARKET SIZE FOR FORENSIC APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
TABLE 18 qPCR REAGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
TABLE 19 NORTH AMERICA: qPCR REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
TABLE 20 U.S.: QPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 21 U.S.: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 22 U.S.: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 23 U.S.: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 24 CANADA: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 25 CANADA: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 26 CANADA: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 27 CANADA: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 28 EUROPE: qPCR REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
TABLE 29 GERMANY: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 30 GERMANY: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 31 GERMANY: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 32 GERMANY: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 33 U.K.: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 34 U.K.: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 35 U.K.: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 36 U.K.: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 37 FRANCE: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 38 FRANCE: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 39 FRANCE: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 40 FRANCE: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 41 ROE: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 42 ROE: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 43 ROE: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 44 ROE: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 45 ASIA-PACIFIC qPCR REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
TABLE 46 JAPAN: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 47 JAPAN: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 48 JAPAN: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 49 JAPAN: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 50 CHINA: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 51 CHINA: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 52 CHINA: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 53 CHINA: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 54 INDIA: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 55 INDIA: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 56 INDIA: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 57 INDIA: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 58 ROAPAC: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 59 ROAPAC: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 60 ROAPAC: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 61 ROAPAC: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 62 ROW: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD, 2013-2020 (USD MILLION)
TABLE 63 ROW: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013-2020 (USD MILLION)
TABLE 64 ROW: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
TABLE 65 ROW: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
TABLE 66 NEW PRODUCT LAUNCHES AND PRODUCT APPROVALS, 2012–2015
TABLE 67 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012–2015
TABLE 68 MERGERS, DEMERGERS, AND ACQUISITIONS, 2012–2015
TABLE 69 GEOGRAPHICAL EXPANSIONS, 2012–2015
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN
FIGURE 2 HEALTHCARE EXPENDITURE ACROSS KEY MARKETS, 2000 VS. 2012
FIGURE 3 HEALTHCARE SPENDING MATRIX: KEY MARKETS, 2013
FIGURE 4 GLOBAL RISE IN PROPORTION OF GERIATRIC POPULATION (2000–2013)
FIGURE 5 INCREASE IN AGING POPULATION, BY COUNTRY, 2005 VS. 2010
FIGURE 6 GLOBAL BURDEN OF CANCER, BY REGION, 2005–2030
FIGURE 7 RISING INCIDENCE OF CANCER ACROSS KEY REGIONS, 2008 VS. 2012
FIGURE 8 ANNUAL CRUDE BIRTH RATE ACROSS KEY GLOBAL MARKETS, 2011
FIGURE 9 PREVALENCE OF HIV INFECTIONS ACROSS THE GLOBE, BY REGION, 2013
FIGURE 10 GLOBAL OUTBREAK OF LEADING INFECTIOUS DISEASES, 1980–2010
FIGURE 11 RAPE AND HOMICIDE CASES ACROSS KEY REGIONS, 2003–2012
FIGURE 12 qPCR PRODUCTS VS. PCR MARKET: A COMPARATIVE STUDY
FIGURE 13 BOTTOM-UP APPROACH
FIGURE 14 TOP-DOWN APPROACH
FIGURE 15 DATA TRIANGULATION
FIGURE 16 ASSUMPTIONS FOR THE RESEARCH STUDY
FIGURE 17 NORTH AMERICA IS EXPECTED TO DOMINATE THE DYE-BASED AND PROBE & PRIMER-BASED qPCR REAGENTS MARKETS BY 2020
FIGURE 18 NORTH AMERICA IS EXPECTED TO DOMINATE THE qPCR CORE KITS & qPCR MASTERMIXES SEGMENTS BY 2020
FIGURE 19 HOSPITALS & DIAGNOSTIC CENTERS SEGMENT WILL CONTINUE TO DOMINATE THE qPCR REAGENTS MARKET IN 2020
FIGURE 20 NORTH AMERICA IS EXPECTED TO DOMINATE THE qPCR REAGENTS MARKET DURING THE FORECAST PERIOD
FIGURE 21 TOP 3 MARKET PLAYERS TO HOLD ~3/4TH MARKET SHARE OF THE qPCR REAGENTS MARKET (2014)
FIGURE 22 ATTRACTIVE GROWTH OPPORTUNITIES IN THE qPCR REAGENTS MARKET
FIGURE 23 NORTH AMERICA IS EXPECTED TO DOMINATE THE DYE-BASED AND PROBE & PRIMER-BASED qPCR REAGENTS MARKETS TILL 2020
FIGURE 24 U.S. IS EXPECTED TO DOMINATE THE qPCR REAGENTS MARKET IN 2015
FIGURE 25 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF KEY qPCR REAGENT APPLICATION SEGMENTS IN 2015
FIGURE 26 CHINA AND INDIA TO LEAD THE MARKET DEMAND FOR qPCR REAGENTS AMONG KEY END USERS DURING THE FORECAST PERIOD
FIGURE 27 qPCR REAGENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
FIGURE 28 HIV PREVALENCE, BY REGION, 2013
FIGURE 29 INCIDENCE OF NEW CANCER CASES WILL BE HIGH AMONG THE GERIATRIC POPULATION
FIGURE 30 TRADITIONAL PCR VS. qPCR: A COMPARATIVE STUDY
FIGURE 31 PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE—DEVELOPED VS. DEVELOPING COUNTRIES (2010–2012)
FIGURE 32 VALUE CHAIN ANALYSIS (2014): MAJOR VALUE IS ADDED DURING THE MANUFACTURING PHASE
FIGURE 33 qPCR REAGENTS MARKET: SUPPLY CHAIN (2014)
FIGURE 34 PRESENCE OF LARGE NUMBER OF NEW ENTRANTS INCREASES MARKET COMPETITION
FIGURE 35 DYE-BASED REAGENTS TO DOMINATE THE qPCR REAGENTS MARKET TILL 2020
FIGURE 36 qPCR CORE KITS TO DOMINATE THE qPCR REAGENTS MARKET REVENUE TILL 2020
FIGURE 37 HOSPITALS & DIAGNOSTIC CENTERS TO DOMINATE THE qPCR REAGENTS END-USER MARKET DURING FORECAST PERIOD (2015–2020)
FIGURE 38 NORTH AMERICA TO DOMINATE THE qPCR REAGENTS MARKET FOR FORENSIC LABORATORIES
FIGURE 39 DIAGNOSTIC APPLICATIONS TO DOMINATE THE qPCR REAGENTS APPLICATION MARKET TILL 2020
FIGURE 40 NORTH AMERICA: qPCR REAGENTS MARKET TRENDS (2015-2020)
FIGURE 41 EUROPE: qPCR REAGENTS MARKET TRENDS (2015-2020)
FIGURE 42 APAC: qPCR REAGENTS MARKET TRENDS (2015-2020)
FIGURE 43 PRODUCT DEVELOPMENT & COMMERCIALIZATION WAS ADOPTED BY MOST LEADING PLAYERS DURING 2012-2015
FIGURE 44 GLOBAL qPCR REAGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2014)
FIGURE 45 MAJORITY OF LEADING MARKET PLAYERS ARE FOCUSED ON PRODUCT LAUNCHES AND APPROVALS AS THEIR KEY GROWTH STRATEGY
FIGURE 46 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS* (2014)
FIGURE 47 LEADING HUMAN QPCR REAGENT MANUFACTURERS FOCUSED ON PRODUCT DEVELOPMENT & COMMERCIALIZATION TO STRENGTHEN THEIR MARKET POSITION
FIGURE 48 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 49 BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
FIGURE 50 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 51 QIAGEN N.V. : COMPANY SNAPSHOT
FIGURE 52 AGILENT TECHNOLOGIES, INC. : COMPANY SNAPSHOT
FIGURE 53 TAKARA BIO, INC.: COMPANY SNAPSHOT
FIGURE 54 AFFYMETRIX, INC.: COMPANY SNAPSHOT
FIGURE 55 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
FIGURE 1 RESEARCH DESIGN
FIGURE 2 HEALTHCARE EXPENDITURE ACROSS KEY MARKETS, 2000 VS. 2012
FIGURE 3 HEALTHCARE SPENDING MATRIX: KEY MARKETS, 2013
FIGURE 4 GLOBAL RISE IN PROPORTION OF GERIATRIC POPULATION (2000–2013)
FIGURE 5 INCREASE IN AGING POPULATION, BY COUNTRY, 2005 VS. 2010
FIGURE 6 GLOBAL BURDEN OF CANCER, BY REGION, 2005–2030
FIGURE 7 RISING INCIDENCE OF CANCER ACROSS KEY REGIONS, 2008 VS. 2012
FIGURE 8 ANNUAL CRUDE BIRTH RATE ACROSS KEY GLOBAL MARKETS, 2011
FIGURE 9 PREVALENCE OF HIV INFECTIONS ACROSS THE GLOBE, BY REGION, 2013
FIGURE 10 GLOBAL OUTBREAK OF LEADING INFECTIOUS DISEASES, 1980–2010
FIGURE 11 RAPE AND HOMICIDE CASES ACROSS KEY REGIONS, 2003–2012
FIGURE 12 qPCR PRODUCTS VS. PCR MARKET: A COMPARATIVE STUDY
FIGURE 13 BOTTOM-UP APPROACH
FIGURE 14 TOP-DOWN APPROACH
FIGURE 15 DATA TRIANGULATION
FIGURE 16 ASSUMPTIONS FOR THE RESEARCH STUDY
FIGURE 17 NORTH AMERICA IS EXPECTED TO DOMINATE THE DYE-BASED AND PROBE & PRIMER-BASED qPCR REAGENTS MARKETS BY 2020
FIGURE 18 NORTH AMERICA IS EXPECTED TO DOMINATE THE qPCR CORE KITS & qPCR MASTERMIXES SEGMENTS BY 2020
FIGURE 19 HOSPITALS & DIAGNOSTIC CENTERS SEGMENT WILL CONTINUE TO DOMINATE THE qPCR REAGENTS MARKET IN 2020
FIGURE 20 NORTH AMERICA IS EXPECTED TO DOMINATE THE qPCR REAGENTS MARKET DURING THE FORECAST PERIOD
FIGURE 21 TOP 3 MARKET PLAYERS TO HOLD ~3/4TH MARKET SHARE OF THE qPCR REAGENTS MARKET (2014)
FIGURE 22 ATTRACTIVE GROWTH OPPORTUNITIES IN THE qPCR REAGENTS MARKET
FIGURE 23 NORTH AMERICA IS EXPECTED TO DOMINATE THE DYE-BASED AND PROBE & PRIMER-BASED qPCR REAGENTS MARKETS TILL 2020
FIGURE 24 U.S. IS EXPECTED TO DOMINATE THE qPCR REAGENTS MARKET IN 2015
FIGURE 25 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF KEY qPCR REAGENT APPLICATION SEGMENTS IN 2015
FIGURE 26 CHINA AND INDIA TO LEAD THE MARKET DEMAND FOR qPCR REAGENTS AMONG KEY END USERS DURING THE FORECAST PERIOD
FIGURE 27 qPCR REAGENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
FIGURE 28 HIV PREVALENCE, BY REGION, 2013
FIGURE 29 INCIDENCE OF NEW CANCER CASES WILL BE HIGH AMONG THE GERIATRIC POPULATION
FIGURE 30 TRADITIONAL PCR VS. qPCR: A COMPARATIVE STUDY
FIGURE 31 PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE—DEVELOPED VS. DEVELOPING COUNTRIES (2010–2012)
FIGURE 32 VALUE CHAIN ANALYSIS (2014): MAJOR VALUE IS ADDED DURING THE MANUFACTURING PHASE
FIGURE 33 qPCR REAGENTS MARKET: SUPPLY CHAIN (2014)
FIGURE 34 PRESENCE OF LARGE NUMBER OF NEW ENTRANTS INCREASES MARKET COMPETITION
FIGURE 35 DYE-BASED REAGENTS TO DOMINATE THE qPCR REAGENTS MARKET TILL 2020
FIGURE 36 qPCR CORE KITS TO DOMINATE THE qPCR REAGENTS MARKET REVENUE TILL 2020
FIGURE 37 HOSPITALS & DIAGNOSTIC CENTERS TO DOMINATE THE qPCR REAGENTS END-USER MARKET DURING FORECAST PERIOD (2015–2020)
FIGURE 38 NORTH AMERICA TO DOMINATE THE qPCR REAGENTS MARKET FOR FORENSIC LABORATORIES
FIGURE 39 DIAGNOSTIC APPLICATIONS TO DOMINATE THE qPCR REAGENTS APPLICATION MARKET TILL 2020
FIGURE 40 NORTH AMERICA: qPCR REAGENTS MARKET TRENDS (2015-2020)
FIGURE 41 EUROPE: qPCR REAGENTS MARKET TRENDS (2015-2020)
FIGURE 42 APAC: qPCR REAGENTS MARKET TRENDS (2015-2020)
FIGURE 43 PRODUCT DEVELOPMENT & COMMERCIALIZATION WAS ADOPTED BY MOST LEADING PLAYERS DURING 2012-2015
FIGURE 44 GLOBAL qPCR REAGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2014)
FIGURE 45 MAJORITY OF LEADING MARKET PLAYERS ARE FOCUSED ON PRODUCT LAUNCHES AND APPROVALS AS THEIR KEY GROWTH STRATEGY
FIGURE 46 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS* (2014)
FIGURE 47 LEADING HUMAN QPCR REAGENT MANUFACTURERS FOCUSED ON PRODUCT DEVELOPMENT & COMMERCIALIZATION TO STRENGTHEN THEIR MARKET POSITION
FIGURE 48 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 49 BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
FIGURE 50 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 51 QIAGEN N.V. : COMPANY SNAPSHOT
FIGURE 52 AGILENT TECHNOLOGIES, INC. : COMPANY SNAPSHOT
FIGURE 53 TAKARA BIO, INC.: COMPANY SNAPSHOT
FIGURE 54 AFFYMETRIX, INC.: COMPANY SNAPSHOT
FIGURE 55 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
